Search results

From Self-sufficiency
Jump to: navigation, search
  • ...rials as an investigational [[antiretroviral]] in humans with [[AIDS|HIV-1/AIDS]] and as a potential [[Antiviral drug|antiviral]] agent against [[chikungun ...g within intracellular [[organelles]] and requiring a low [[pH]]. As for [[HIV-1]], chloroquine inhibits the [[glycosylation]] of the [[viral envelope]]
    16 KB (2,187 words) - 15:41, 27 September 2010
  • ...correlated with muscle wasting ([[cachexia]]), a condition associated with AIDS. * N-acetylcysteine replenishes glutathione in HIV infection. "[http://nacsupplements.com/?p=11]"
    28 KB (3,682 words) - 15:42, 27 September 2010
  • ===HIV=== Being an antibiotic, co-trimoxazole does not have any activity against HIV itself, but it is often prescribed to immunocompromised patients as [[Pneum
    10 KB (1,346 words) - 15:43, 27 September 2010
  • ...log [[reverse transcriptase inhibitor]] (NRTI) used to treat [[HIV]] and [[AIDS]]. It is available under the trade name '''Ziagen''' ([[GlaxoSmithKline]]) ...ation with other antiretroviral agents, are indicated for the treatment of HIV-1 infection.
    8 KB (1,124 words) - 15:44, 27 September 2010
  • ...ex EC'''. It is a [[reverse transcriptase inhibitor]], effective against [[HIV]] and used in combination with other [[antiretroviral drug]] therapy as par ...ical trials showing that didanosine had activity in patients infected with HIV. On behalf of the NCI, they were awarded patents on these activities. Since
    9 KB (1,239 words) - 15:44, 27 September 2010
  • ...cleoside analog reverse transcriptase inhibitor]] (NARTI) active against [[HIV]]. ...istory of an AIDS drug].</ref> It was subsequently reconsidered as an anti-HIV agent by the [[Rega Institute for Medical Research]] in [[Belgium]]. Stavud
    4 KB (574 words) - 15:44, 27 September 2010
  • ...lock [[reverse transcriptase]], an enzyme crucial to viral production in [[HIV]]-infected people. ...6 and is now available, providing a single daily dose for the treatment of HIV.
    6 KB (871 words) - 15:45, 27 September 2010
  • ...l therapy]] (HAART) for the treatment of a human immunodeficiency virus ([[HIV]]) type 1. For HIV infection that has not previously been treated, the [[United States Departm
    10 KB (1,441 words) - 15:45, 27 September 2010
  • ...nscriptase inhibitor]] (NNRTI) used to treat [[HIV|HIV-1]] infection and [[AIDS]]. As with other [[antiretroviral drug]]s, HIV rapidly develops resistance if nevirapine is used alone, so recommended the
    15 KB (2,090 words) - 15:45, 27 September 2010
  • ...y active antiretroviral therapy]] (HAART) to treat [[HIV]] infection and [[AIDS]]. ...antiretroviral drugs. Protease inhibitors changed the very nature of the AIDS epidemic from one of a terminal illness to a somewhat manageable one.
    3 KB (320 words) - 14:07, 6 July 2010
  • ...of [[ritonavir]], as a component of combination therapy to treat [[HIV]]/[[AIDS]]. The Kaletra formulation has also been used successfully as monotherapy i ...name="dhhs">DHHS panel. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (May 4, 2006). (Available for download fr
    8 KB (1,109 words) - 15:45, 27 September 2010
  • ...macology)|protease inhibitor]] class used to treat [[HIV]] infection and [[AIDS]]. ...post.com/wp-dyn/articles/A40430-2004Aug4.html| title=NIH Declines to Enter AIDS Drug Price Battle| accessdate=2006-01-16| author=Ceci Connolly| publisher=W
    9 KB (1,233 words) - 14:07, 6 July 2010
  • ...ces]]'s [[tenofovir]] and [[emtricitabine]] (already available in the anti-HIV combination [[Truvada]]) with [[Bristol-Myers Squibb]]'s [[efavirenz]] into ...n between two U.S. pharmaceutical companies to combine their patented anti-HIV drugs into one product.<ref>{{cite web | author= | title=Search for Tradena
    6 KB (773 words) - 15:45, 27 September 2010
  • '''Saquinavir''' is an [[antiretroviral drug]] used in [[HIV]] therapy. It falls in the [[protease inhibitor (pharmacology)|protease inh ...viral particles from an infected cell. Saquinavir inhibits both HIV-1 and HIV-2 proteases.
    5 KB (717 words) - 14:07, 6 July 2010
  • ...terferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients |journal=N. Engl. J. Med. |volume=351 |issue=5 |pages=438 ...eractions with nucleoside antivirals for HIV should be considered when HIV/AIDS patients use ribavirin to treat hepatitis C (see "aidsinfo" external link).
    23 KB (3,222 words) - 15:45, 27 September 2010
  • }}</ref> AIDS-related Kaposi's sarcoma,<ref name="pmid16942436">{{Cite journal | title = New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma
    27 KB (3,650 words) - 15:46, 27 September 2010
  • ...istone deacetylase inhibitor]] and is under investigation for treatment of HIV and various cancers. ====HIV====
    25 KB (3,328 words) - 15:47, 27 September 2010
  • ...]] (NRTI), a type of [[antiretroviral drug]] used for the treatment of HIV/AIDS. It is an [[analog (chemistry)|analog]] of [[thymidine]]. ...slows HIV spread significantly, but does not stop it entirely. This allows HIV to become AZT resistant over time, and for this reason AZT is usually used
    21 KB (3,049 words) - 15:51, 27 September 2010
  • ...ntidiarrheal]] in chronic conditions (e.g., for diarrhea associated with [[AIDS]], although [[loperamide]] (a non-absorbed opioid acting only on the gut) i ...reased [[pneumonia]], [[tuberculosis]], and [[Human immunodeficiency virus|HIV]]) led scientists to believe that morphine may also affect the [[immune sys
    87 KB (12,376 words) - 15:51, 27 September 2010
  • ...ntiviral protein, with subtypes taken from leaves in different seasons for AIDS. Oleanolic acid would be the constituent of choice for standardizing for th ...summer leaves) that cause concentration-dependent depurination of genomic HIV-1 RNA.<ref name=autogenerated1 /><ref>{{cite journal |author=Bodger MP, McG
    16 KB (2,229 words) - 11:26, 7 July 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)